By InvitationPhase 1

Dexamethasone vs Dexmedetomidine in Sphenopalatine Ganglion Block for Rhinoplasty Pain

Egypt90 participantsStarted 2026-02-01

Plain-language summary

This study will test the effect of adding dexamethasone versus dexmedetomidine as adjuvants to bupivacaine in sphenopalatine ganglion block used for pain after rhinoplasty

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18-65 years.
✓. Sex: of either sex.
✓. American Society of Anaesthesiologists (ASA) Physical Status Class I and II.
✓. BMI \< 35
✓. Scheduled for rhinoplasty surgeries under general anaesthesia.

Exclusion criteria

✕. Declining to give written informed consent.
✕. History of allergy to the medications used in the study.
✕. Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
✕. Psychiatric disorder.

What they're measuring

The time to the first request of analgesia

Timeframe: 9 months

Trial details

NCT IDNCT07380139

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-01

View on ClinicalTrials.gov More Post Operative Pain trials